USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: PHARMABRIDGE, INC.
City: DOYLESTOWN
State: PA
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $240,146.00 1
SBIR Phase II $3,000,000.00 1

Award List:

Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $240,146.00
Abstract:
DESCRIPTION (provided by applicant): Our proposal centers on the development of a novel antiviral compound for therapy of hepatitis B patients. Hepatitis B surface antigen (HBsAg) is an essential viral gene product, and its high levels in the circulation m ay play a role in immunosuppression.… More

Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Andrea Cuconati – 215-489-4918
Award Amount: $3,000,000.00
Abstract:
DESCRIPTION (provided by applicant): This is a Phase II proposal to advance development of disubstituted tetrahydro-triazolo-pyrimidines (TTPs) as specific inhibitors of hepatitis B virus surface antigen (HBsAg) secretion in chronic infection. High serum levels of HBsAg (antigenemia) are believed to… More